论文部分内容阅读
ＤｕＰｏｎｔ公司的低分子肝素产品亭扎肝素钠（ｔｉｎｚａｐａｒｉｎｓｏｄｉｕｍ，Ｉｎｎｏｈｅｐ）在美国上市用于急性症状性深静脉血栓的治疗，以及与华法林联合用于肺栓塞的治疗。 仅有Ｄａｎｉｓｈ公司的一日１次低分子肝素产品获准用于所有深静脉栓塞病人。ＤｕＰｏｎｔ
DuPont’s low-molecular-weight heparin product tinzaparin sodium (Innohep) is marketed in the United States for the treatment of acute symptomatic DVTs and in combination with warfarin for pulmonary embolism. Only Danish’s low-molecular-weight once-daily heparin product is approved for use in all patients with deep vein thrombosis. DuPont